EARNEST PARTNERS LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$55,711,427
-26.1%
3,473,281
+6.7%
0.32%
-23.9%
Q2 2023$75,422,574
+6.1%
3,253,778
+6.3%
0.42%
+2.7%
Q1 2023$71,103,267
+48.3%
3,060,838
-7.4%
0.41%
+39.8%
Q4 2022$47,947,657
-61.8%
3,304,456
-49.7%
0.29%
-65.1%
Q3 2022$125,363,000
+6.8%
6,570,402
+1.7%
0.84%
+7.7%
Q2 2022$117,417,000
-25.8%
6,462,138
+2.9%
0.78%
-16.5%
Q1 2022$158,182,000
-9.3%
6,277,060
-0.6%
0.94%
-6.9%
Q4 2021$174,332,000
-13.6%
6,316,365
+1.0%
1.01%
-18.5%
Q3 2021$201,871,000
+6.6%
6,251,811
+0.9%
1.23%
+10.9%
Q2 2021$189,397,000
-13.4%
6,193,479
-13.8%
1.11%
-14.8%
Q1 2021$218,794,000
+64.4%
7,185,350
+6.7%
1.31%
+42.1%
Q4 2020$133,114,000
+106.4%
6,731,429
+36.1%
0.92%
+65.5%
Q3 2020$64,491,000
+19.4%
4,945,610
+3.9%
0.56%
+9.0%
Q2 2020$53,991,000
-9.3%
4,761,082
+14.4%
0.51%
-24.0%
Q1 2020$59,534,000
-39.2%
4,160,284
+15.6%
0.67%
-12.9%
Q4 2019$97,994,000
+1.0%
3,598,750
+6.2%
0.77%
-12.1%
Q3 2019$97,006,0003,388,2490.88%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 2,750,000$75,900,0002.61%
PFM Health Sciences, LP 2,025,681$55,909,0001.90%
Tieton Capital Management, LLC 118,456$3,269,0001.83%
Altium Capital Management LP 190,000$5,244,0001.45%
DISCIPLINED GROWTH INVESTORS INC /MN 1,846,490$50,963,0001.03%
EARNEST PARTNERS LLC 6,316,365$174,332,0001.01%
Glenview Capital Management 1,679,747$46,361,0000.99%
Zebra Capital Management LLC 14,209$392,0000.63%
AIMZ Investment Advisors, LLC 44,185$1,220,0000.48%
Phocas Financial Corp. 132,101$3,646,0000.46%
View complete list of MYRIAD GENETICS INC shareholders